PAH

Actelion says selexipag to enter U.S. market in January
Yahoo/Reuters
Tue, 12/22/15 - 10:56 am
Actelion
selexipag
Uptravi
PAH
pulmonary arterial hypertension
With Opsumit launch rolling, Actelion doesn't 'need' M&A: CEO
Fierce Pharma
Tue, 10/20/15 - 09:53 pm
Actelion
Opsumit
M&A
PAH
pulmonary arterial hypertension
Gilead Sciences Letairis Wins FDA Nod For PAH: Stock To Recover Soon
Bidness, ETC
Tue, 10/6/15 - 09:51 am
PAH
pulmonary arterial hypertension
FDA
Gilead Sciences
Letairis
Bellerophon shares skyrocket on high blood pressure drug study
Marketwatch
Thu, 09/24/15 - 07:19 pm
Bellerophon
PAH
Inopulse
clinical trials
pulmonary arterial hypertension
Actelion's Opsumit growth heralds smooth switch off aging Tracleer
Fierce Pharma
Tue, 07/21/15 - 10:34 am
Actelion
Opsumit
Tracleer
PAH
pulmonary arterial hypertension
Actavis seeking FDA Approval to market generic version of Gilead drug
Marketwatch
Fri, 04/3/15 - 10:35 am
Actavis
FDA
generics
Gilead Sciences
Letairis
PAH
Deep dive into Actelion's Uptravi data calms investors as FDA decision date nears
Fierce Biotech
Wed, 03/18/15 - 11:08 am
Actelion
Uptravi
PAH
pulmonary arterial hypertension
Drug-device biotech SteadyMed swings for a $55M IPO
Fierce Biotech
Mon, 02/9/15 - 09:07 pm
devices
SteadyMed
IPOs
biotech
PAH
GSK and Gilead’s combination therapy: positive results in PAH
Pharmaphorum
Tue, 09/9/14 - 10:36 am
GSK
Gilead Sciences
PAH
pulmonary arterial hypertension
Letairis
Adcirca
Arena Pharmaceuticals' APD811 Gets Orphan Drug Status
Yahoo/Zacks.com
Thu, 09/4/14 - 08:01 am
Arena Pharmaceuticals
APD811
orphan drugs
PAH
pulmonary arterial hypertension
Actelion’s Lung Drug May Face Study Against Gilead Rival
Bloomberg
Wed, 02/12/14 - 09:50 am
Actelion
Gilead Sciences
Opsumit
Letairis
PAH
pulmonary arterial hypertension
Actelion gets second boost for Opsumit with EU approval
Fierce Pharma
Mon, 12/23/13 - 03:23 pm
Actelion
Opsumit
Europe
Tracleer
PAH
pulmonary arterial hypertension
United Therapeutics Shares Gain on FDA Hypertension Approval
Bloomberg
Mon, 12/23/13 - 11:27 am
FDA
United Therapeutics
PAH
pulmonary arterial hypertension
Did One Of The Top 10 Upside Surprises In The History Of The Biotech Sector Just Happen?
Forbes
Mon, 12/23/13 - 10:22 am
Remodulin
PAH
pulmonary arterial hypertension
Orenitram
United Therapeutics
United Therapeutics receives subpoena for 3 drugs
Yahoo/AP
Mon, 12/9/13 - 10:09 am
United Therapeutics
PAH
Remodulin
Tyvaso
Adcirca
pulmonary arterial hypertension
Actelion hits 6-yr high after favourable FDA approval for drug
Yahoo/Reuters
Mon, 10/21/13 - 08:36 am
FDA
Actelion
Opsumit
PAH
Actelion Wins U.S. FDA Approval for Lung Disorder Therapy
Bloomberg
Fri, 10/18/13 - 05:47 pm
Actelion
FDA
Opsumit
PAH
Patient in Arena lung drug trial experiences heart problem
Reuters
Thu, 08/29/13 - 10:27 am
Arena Pharmaceuticals
APD811
PAH
pulmonary arterial hypertension
Arena Pharmaceuticals' candidate for pulmonary hypertension completes Phase 1b
Yahoo/Fly on the Wall
Wed, 08/28/13 - 10:45 am
PAH
pulmonary arterial hypertension
Arena Pharmaceuticals
APD811
United Therapeutics' Second PAH Stumble Emphasizes The Need For Pluristem's Therapy
Seeking Alpha
Tue, 04/30/13 - 08:37 am
United Therapeutics
PAH
pulmonary arterial hypertension
Remodulin
Pluristem Therapeutics

Pages